H.C. Wainwright Downgrades VYNE Therapeutics (VYNE) to Neutral
Tweet Send to a Friend
(Updated - July 30, 2025 10:19 AM EDT)
H.C. Wainwright analyst Joseph Pantginis downgraded VYNE Therapeutics (NASDAQ: VYNE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Joseph Pantginis downgraded VYNE Therapeutics (NASDAQ: VYNE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
